Literature DB >> 2902344

Reversible bronchoconstriction with nebulised pentamidine.

D E Smith, D Herd, B G Gazzard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2902344     DOI： 10.1016/s0140-6736(88)92500-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Pneumocystis carinii pneumonia.

Authors:  S Thomas; M O'Doherty; N Bateman
Journal:  BMJ       Date:  1990-01-27

2.  Nebulisers for patients with HIV infection and AIDS.

Authors:  R F Miller; M J O'Doherty
Journal:  Thorax       Date:  1997-04       Impact factor: 9.139

Review 3.  Inhaled pentamidine. An overview of its pharmacological properties and a review of its therapeutic use in Pneumocystis carinii pneumonia.

Authors:  J P Monk; P Benfield
Journal:  Drugs       Date:  1990-05       Impact factor: 9.546

Review 4.  Pentamidine. A risk-benefit analysis.

Authors:  B Wispelwey; R Pearson
Journal:  Drug Saf       Date:  1990 May-Jun       Impact factor: 5.606

5.  Nebulised pentamidine as treatment for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome.

Authors:  R F Miller; P Godfrey-Faussett; S J Semple
Journal:  Thorax       Date:  1989-07       Impact factor: 9.139

6.  Effect of terbutaline on bronchoconstriction induced by nebulised pentamidine.

Authors:  T R Leigh; J Wiggins; B G Gazzard; J V Collins
Journal:  Thorax       Date:  1991-02       Impact factor: 9.139

Review 7.  Treatment and prophylaxis of Pneumocystis carinii pneumonia in AIDS patients.

Authors:  D Smith; B Gazzard
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.